🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Florence Joly

Centre François Baclesse

ORCID: 0000-0001-6168-4942

Also affiliated with Centre François Baclesse

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial”.

Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial

The Lancet Oncology(2022)10.1016/s1470-2045(21)00757-9

N/A

4.9DataRank · unranked

188 citations

Howard I Scher, Shahneen Sandhu, Eleni Efstathiou, Primo N Lara, Evan Y Yu +90 more

Impact of taxane-based chemotherapy among older women with breast cancer on cognition and quality of life: a longitudinal pooled analysis

Breast Cancer Research and Treatment(2021)10.1007/s10549-021-06455-6

N/A

0DataRank · unranked

4 citations

Marie Lange, Wanting Zhai, Jaeil Ahn, Tim A. Ahles, Judith Carroll +15 more

Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Annals of Oncology(2022)10.1016/j.annonc.2022.05.009

N/A

0DataRank · unranked

636 citations

Tjalling Bosse, Carien L. Creutzberg, Gonzalo Giornelli, Philipp Harter, Florence Joly +7 more